tirzepatide for obesity fda approval #Zepbound (#tirzepatide aka #mounjaro) just got approved the management of Obesity. Previously, Mounjaro was only approved for #diabetes. This is great news! #t2d #t2diabetes #tiktokpartner Zepbound® — A New Treatment

We know from extensive research that people with diabetes are at a much higher risk for heart disease, explains Toby Smithson, RDN, CDE, a spokesperson for the American Association of Diabetes Educators

doi: 10.1128/IAI.01377-09 316 TakahashiH.HiroseK.WatanabeH

The page should help readers prepare for a clinician conversation, not encourage self-treatment from a generic protocol

Women using oral contraceptives should use alternative or back-up contraception for 4 weeks after tirzepatide initiation and after each dose increase due to potential reduced effectiveness from delayed gastric emptying

$26.95Out of stock Lidocaine HCl 2% Injection